Amgen announces positive results for migraine drug
Thousand Oaks-based biotech giant Amgen announced positive data from a phase 3 study of a new migraine drug co-developed with competitor Novartis. Amgen said in a news release that, after 12 weeks, Erenumab showed a significant reduction in monthly migraine days in patients with episodic migraines treated with Erenumab compared with a placebo. In the Read More →
Read More →CalAmp misses analyst estimates for second quarter
CalAmp fell short of revenue and earnings per share estimates for the second quarter, the company reported Sept. 29. Net income was $521,000, which was down from $3.4 million in the second quarter of 2015. CalAmp posted revenues of $90.5 million, up from revenues of $69.8 million during the same quarter in 2015 but just Read More →
Read More →Brown signs bill lowering blood alcohol content limit for ridesharing service drivers
Gov. Jerry Brown signed a bill Sept. 29 that lowers the legally allowed blood alcohol content levels for drivers hired by ride-sharing services. Rep. Katcho Achadjian, D-San Luis Obispo, authored the bill, AB 2687, which says drivers hired by ride sharing services must follow the same blood alcohol content guidelines as commercial drivers. Under current Read More →
Read More →Calavo Growers to pay 90 cent dividend per share
The board of directors for Santa Paula-based Calavo Growers announced Sept. 27 that it would pay a 90 cent dividend per share of its common stock. The dividend is payable Dec. 8 to shareholders of record Nov. 17 and amounts to $15.7 million, a 12.5 percent increase over an 80 cent dividend 2015. Calavo stock Read More →
Read More →SpaceX could resume rocket launches by November
SpaceX on Sept. 23 updated the status of an investigation into a recent explosion at a Florida launch pad that postponed a launch at Vandenberg Air Force Base indefinitely. The September explosion indefinitely delayed the launch of a rocket originally scheduled to launch from Vandenberg on Sept. 19, but the company said it could resume Read More →
Read More →Largest industrial building in Thousand Oaks sells for $37 million
The largest industrial building in Thousand Oaks was sold for $37 million, according to CBRE. Van Nuys-based real estate company Majestic Asset Management purchased the fully leased property at 1461-1475 Lawrence Drive from Austin, Texas-based Western National Life Insurance Co., a subsidiary of AIG. Majestic secured a $26.6 million balance sheet loan for the deal, Read More →
Read More →FDA approves Amgen biosimilar of AbbVie’s Humira
The Food and Drug Administration approved Amgen’s Humira biosimilar Sept. 23. Amjevita, formerly known as ABP 501 and made by Thousand Oaks-biotech giant Amgen, replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and colon inflammation. Humira, made by Chicago-based competitor AbbVie, typically costs $20,000 per year Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
